The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tadalafil Oral Market Research Report 2025
Synopsis
Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).
The global Tadalafil Oral market was valued at US$ 127 million in 2023 and is anticipated to reach US$ 162 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Tadalafil oral is a medication used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It is marketed under various brand names, including Cialis. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which work by increasing blood flow to the penis, helping men achieve and maintain an erection. Market trends for tadalafil can vary over time and across regions. Factors such as the introduction of generic versions, changes in pricing, competition from other ED medications, and consumer preferences can influence market dynamics. According to recent market research reports, the global tadalafil oral market is expected to grow due to increasing cases of erectile dysfunction and benign prostatic hyperplasia among the aging population, as well as growing awareness and healthcare expenditure for these conditions. Additionally, the availability of various formulation types and convenience in purchasing medication online are expected to drive market growth.
This report aims to provide a comprehensive presentation of the global market for Tadalafil Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tadalafil Oral.
Report Scope
The Tadalafil Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tadalafil Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tadalafil Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Teva
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan
Cipla
Ajanta Pharma Ltd.
Dr. Reddys Laboratories
Qilu Pharmaceutical
Segment by Type
2.5 mg tablets
5 mg tablets
10mg tablets
20 mg tablets
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tadalafil Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tadalafil Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).
The global Tadalafil Oral market was valued at US$ 127 million in 2023 and is anticipated to reach US$ 162 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Tadalafil oral is a medication used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It is marketed under various brand names, including Cialis. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which work by increasing blood flow to the penis, helping men achieve and maintain an erection. Market trends for tadalafil can vary over time and across regions. Factors such as the introduction of generic versions, changes in pricing, competition from other ED medications, and consumer preferences can influence market dynamics. According to recent market research reports, the global tadalafil oral market is expected to grow due to increasing cases of erectile dysfunction and benign prostatic hyperplasia among the aging population, as well as growing awareness and healthcare expenditure for these conditions. Additionally, the availability of various formulation types and convenience in purchasing medication online are expected to drive market growth.
This report aims to provide a comprehensive presentation of the global market for Tadalafil Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tadalafil Oral.
Report Scope
The Tadalafil Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tadalafil Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tadalafil Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Teva
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan
Cipla
Ajanta Pharma Ltd.
Dr. Reddys Laboratories
Qilu Pharmaceutical
Segment by Type
2.5 mg tablets
5 mg tablets
10mg tablets
20 mg tablets
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tadalafil Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tadalafil Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tadalafil Oral Market Overview
1.1 Product Overview and Scope of Tadalafil Oral
1.2 Tadalafil Oral Segment by Type
1.2.1 Global Tadalafil Oral Market Value Comparison by Type (2024-2030)
1.2.2 2.5 mg tablets
1.2.3 5 mg tablets
1.2.4 10mg tablets
1.2.5 20 mg tablets
1.3 Tadalafil Oral Segment by Application
1.3.1 Global Tadalafil Oral Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Tadalafil Oral Market Size Estimates and Forecasts
1.4.1 Global Tadalafil Oral Revenue 2019-2030
1.4.2 Global Tadalafil Oral Sales 2019-2030
1.4.3 Global Tadalafil Oral Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tadalafil Oral Market Competition by Manufacturers
2.1 Global Tadalafil Oral Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tadalafil Oral Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tadalafil Oral Average Price by Manufacturers (2019-2024)
2.4 Global Tadalafil Oral Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tadalafil Oral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tadalafil Oral, Product Type & Application
2.7 Tadalafil Oral Market Competitive Situation and Trends
2.7.1 Tadalafil Oral Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tadalafil Oral Players Market Share by Revenue
2.7.3 Global Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tadalafil Oral Retrospective Market Scenario by Region
3.1 Global Tadalafil Oral Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tadalafil Oral Global Tadalafil Oral Sales by Region: 2019-2030
3.2.1 Global Tadalafil Oral Sales by Region: 2019-2024
3.2.2 Global Tadalafil Oral Sales by Region: 2025-2030
3.3 Global Tadalafil Oral Global Tadalafil Oral Revenue by Region: 2019-2030
3.3.1 Global Tadalafil Oral Revenue by Region: 2019-2024
3.3.2 Global Tadalafil Oral Revenue by Region: 2025-2030
3.4 North America Tadalafil Oral Market Facts & Figures by Country
3.4.1 North America Tadalafil Oral Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tadalafil Oral Sales by Country (2019-2030)
3.4.3 North America Tadalafil Oral Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tadalafil Oral Market Facts & Figures by Country
3.5.1 Europe Tadalafil Oral Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tadalafil Oral Sales by Country (2019-2030)
3.5.3 Europe Tadalafil Oral Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tadalafil Oral Market Facts & Figures by Country
3.6.1 Asia Pacific Tadalafil Oral Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tadalafil Oral Sales by Country (2019-2030)
3.6.3 Asia Pacific Tadalafil Oral Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tadalafil Oral Market Facts & Figures by Country
3.7.1 Latin America Tadalafil Oral Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tadalafil Oral Sales by Country (2019-2030)
3.7.3 Latin America Tadalafil Oral Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tadalafil Oral Market Facts & Figures by Country
3.8.1 Middle East and Africa Tadalafil Oral Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tadalafil Oral Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tadalafil Oral Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tadalafil Oral Sales by Type (2019-2030)
4.1.1 Global Tadalafil Oral Sales by Type (2019-2024)
4.1.2 Global Tadalafil Oral Sales by Type (2025-2030)
4.1.3 Global Tadalafil Oral Sales Market Share by Type (2019-2030)
4.2 Global Tadalafil Oral Revenue by Type (2019-2030)
4.2.1 Global Tadalafil Oral Revenue by Type (2019-2024)
4.2.2 Global Tadalafil Oral Revenue by Type (2025-2030)
4.2.3 Global Tadalafil Oral Revenue Market Share by Type (2019-2030)
4.3 Global Tadalafil Oral Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tadalafil Oral Sales by Application (2019-2030)
5.1.1 Global Tadalafil Oral Sales by Application (2019-2024)
5.1.2 Global Tadalafil Oral Sales by Application (2025-2030)
5.1.3 Global Tadalafil Oral Sales Market Share by Application (2019-2030)
5.2 Global Tadalafil Oral Revenue by Application (2019-2030)
5.2.1 Global Tadalafil Oral Revenue by Application (2019-2024)
5.2.2 Global Tadalafil Oral Revenue by Application (2025-2030)
5.2.3 Global Tadalafil Oral Revenue Market Share by Application (2019-2030)
5.3 Global Tadalafil Oral Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly Tadalafil Oral Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Tadalafil Oral Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Aurobindo
6.3.1 Aurobindo Corporation Information
6.3.2 Aurobindo Description and Business Overview
6.3.3 Aurobindo Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Tadalafil Oral Product Portfolio
6.3.5 Aurobindo Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma Tadalafil Oral Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Corporation Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alembic Pharmaceuticals Tadalafil Oral Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Tadalafil Oral Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Tadalafil Oral Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Ajanta Pharma Ltd.
6.8.1 Ajanta Pharma Ltd. Corporation Information
6.8.2 Ajanta Pharma Ltd. Description and Business Overview
6.8.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ajanta Pharma Ltd. Tadalafil Oral Product Portfolio
6.8.5 Ajanta Pharma Ltd. Recent Developments/Updates
6.9 Dr. Reddys Laboratories
6.9.1 Dr. Reddys Laboratories Corporation Information
6.9.2 Dr. Reddys Laboratories Description and Business Overview
6.9.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr. Reddys Laboratories Tadalafil Oral Product Portfolio
6.9.5 Dr. Reddys Laboratories Recent Developments/Updates
6.10 Qilu Pharmaceutical
6.10.1 Qilu Pharmaceutical Corporation Information
6.10.2 Qilu Pharmaceutical Description and Business Overview
6.10.3 Qilu Pharmaceutical Tadalafil Oral Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Qilu Pharmaceutical Tadalafil Oral Product Portfolio
6.10.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tadalafil Oral Industry Chain Analysis
7.2 Tadalafil Oral Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tadalafil Oral Production Mode & Process
7.4 Tadalafil Oral Sales and Marketing
7.4.1 Tadalafil Oral Sales Channels
7.4.2 Tadalafil Oral Distributors
7.5 Tadalafil Oral Customers
8 Tadalafil Oral Market Dynamics
8.1 Tadalafil Oral Industry Trends
8.2 Tadalafil Oral Market Drivers
8.3 Tadalafil Oral Market Challenges
8.4 Tadalafil Oral Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tadalafil Oral Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tadalafil Oral Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tadalafil Oral Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tadalafil Oral Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tadalafil Oral Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tadalafil Oral Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tadalafil Oral Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tadalafil Oral Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tadalafil Oral, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tadalafil Oral, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tadalafil Oral, Product Type & Application
Table 12. Global Key Manufacturers of Tadalafil Oral, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tadalafil Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tadalafil Oral as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tadalafil Oral Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tadalafil Oral Sales by Region (2019-2024) & (K Units)
Table 18. Global Tadalafil Oral Sales Market Share by Region (2019-2024)
Table 19. Global Tadalafil Oral Sales by Region (2025-2030) & (K Units)
Table 20. Global Tadalafil Oral Sales Market Share by Region (2025-2030)
Table 21. Global Tadalafil Oral Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tadalafil Oral Revenue Market Share by Region (2019-2024)
Table 23. Global Tadalafil Oral Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tadalafil Oral Revenue Market Share by Region (2025-2030)
Table 25. North America Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tadalafil Oral Sales by Country (2019-2024) & (K Units)
Table 27. North America Tadalafil Oral Sales by Country (2025-2030) & (K Units)
Table 28. North America Tadalafil Oral Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tadalafil Oral Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tadalafil Oral Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tadalafil Oral Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tadalafil Oral Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tadalafil Oral Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tadalafil Oral Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tadalafil Oral Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tadalafil Oral Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tadalafil Oral Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tadalafil Oral Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tadalafil Oral Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tadalafil Oral Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tadalafil Oral Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tadalafil Oral Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tadalafil Oral Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Tadalafil Oral Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Tadalafil Oral Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tadalafil Oral Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tadalafil Oral Sales (K Units) by Type (2019-2024)
Table 51. Global Tadalafil Oral Sales (K Units) by Type (2025-2030)
Table 52. Global Tadalafil Oral Sales Market Share by Type (2019-2024)
Table 53. Global Tadalafil Oral Sales Market Share by Type (2025-2030)
Table 54. Global Tadalafil Oral Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tadalafil Oral Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tadalafil Oral Revenue Market Share by Type (2019-2024)
Table 57. Global Tadalafil Oral Revenue Market Share by Type (2025-2030)
Table 58. Global Tadalafil Oral Price (USD/Unit) by Type (2019-2024)
Table 59. Global Tadalafil Oral Price (USD/Unit) by Type (2025-2030)
Table 60. Global Tadalafil Oral Sales (K Units) by Application (2019-2024)
Table 61. Global Tadalafil Oral Sales (K Units) by Application (2025-2030)
Table 62. Global Tadalafil Oral Sales Market Share by Application (2019-2024)
Table 63. Global Tadalafil Oral Sales Market Share by Application (2025-2030)
Table 64. Global Tadalafil Oral Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tadalafil Oral Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tadalafil Oral Revenue Market Share by Application (2019-2024)
Table 67. Global Tadalafil Oral Revenue Market Share by Application (2025-2030)
Table 68. Global Tadalafil Oral Price (USD/Unit) by Application (2019-2024)
Table 69. Global Tadalafil Oral Price (USD/Unit) by Application (2025-2030)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Eli Lilly Tadalafil Oral Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Tadalafil Oral Product
Table 79. Teva Recent Developments/Updates
Table 80. Aurobindo Corporation Information
Table 81. Aurobindo Description and Business Overview
Table 82. Aurobindo Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Aurobindo Tadalafil Oral Product
Table 84. Aurobindo Recent Developments/Updates
Table 85. Sun Pharma Corporation Information
Table 86. Sun Pharma Description and Business Overview
Table 87. Sun Pharma Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharma Tadalafil Oral Product
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Alembic Pharmaceuticals Corporation Information
Table 91. Alembic Pharmaceuticals Description and Business Overview
Table 92. Alembic Pharmaceuticals Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Alembic Pharmaceuticals Tadalafil Oral Product
Table 94. Alembic Pharmaceuticals Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Mylan Tadalafil Oral Product
Table 99. Mylan Recent Developments/Updates
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Cipla Tadalafil Oral Product
Table 104. Cipla Recent Developments/Updates
Table 105. Ajanta Pharma Ltd. Corporation Information
Table 106. Ajanta Pharma Ltd. Description and Business Overview
Table 107. Ajanta Pharma Ltd. Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Ajanta Pharma Ltd. Tadalafil Oral Product
Table 109. Ajanta Pharma Ltd. Recent Developments/Updates
Table 110. Dr. Reddys Laboratories Corporation Information
Table 111. Dr. Reddys Laboratories Description and Business Overview
Table 112. Dr. Reddys Laboratories Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Dr. Reddys Laboratories Tadalafil Oral Product
Table 114. Dr. Reddys Laboratories Recent Developments/Updates
Table 115. Qilu Pharmaceutical Corporation Information
Table 116. Qilu Pharmaceutical Description and Business Overview
Table 117. Qilu Pharmaceutical Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Qilu Pharmaceutical Tadalafil Oral Product
Table 119. Qilu Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Tadalafil Oral Distributors List
Table 123. Tadalafil Oral Customers List
Table 124. Tadalafil Oral Market Trends
Table 125. Tadalafil Oral Market Drivers
Table 126. Tadalafil Oral Market Challenges
Table 127. Tadalafil Oral Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tadalafil Oral
Figure 2. Global Tadalafil Oral Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tadalafil Oral Market Share by Type in 2023 & 2030
Figure 4. 2.5 mg tablets Product Picture
Figure 5. 5 mg tablets Product Picture
Figure 6. 10mg tablets Product Picture
Figure 7. 20 mg tablets Product Picture
Figure 8. Global Tadalafil Oral Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Tadalafil Oral Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Drug store
Figure 12. Global Tadalafil Oral Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tadalafil Oral Market Size (2019-2030) & (US$ Million)
Figure 14. Global Tadalafil Oral Sales (2019-2030) & (K Units)
Figure 15. Global Tadalafil Oral Average Price (USD/Unit) & (2019-2030)
Figure 16. Tadalafil Oral Report Years Considered
Figure 17. Tadalafil Oral Sales Share by Manufacturers in 2023
Figure 18. Global Tadalafil Oral Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Tadalafil Oral Players: Market Share by Revenue in 2023
Figure 20. Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Tadalafil Oral Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Tadalafil Oral Sales Market Share by Country (2019-2030)
Figure 23. North America Tadalafil Oral Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Tadalafil Oral Sales Market Share by Country (2019-2030)
Figure 27. Europe Tadalafil Oral Revenue Market Share by Country (2019-2030)
Figure 28. Germany Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Tadalafil Oral Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Tadalafil Oral Revenue Market Share by Region (2019-2030)
Figure 35. China Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Tadalafil Oral Sales Market Share by Country (2019-2030)
Figure 46. Latin America Tadalafil Oral Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Tadalafil Oral Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Tadalafil Oral Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Tadalafil Oral Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Tadalafil Oral by Type (2019-2030)
Figure 56. Global Revenue Market Share of Tadalafil Oral by Type (2019-2030)
Figure 57. Global Tadalafil Oral Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Tadalafil Oral by Application (2019-2030)
Figure 59. Global Revenue Market Share of Tadalafil Oral by Application (2019-2030)
Figure 60. Global Tadalafil Oral Price (USD/Unit) by Application (2019-2030)
Figure 61. Tadalafil Oral Value Chain
Figure 62. Tadalafil Oral Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
